Stay updated on NANT HNSCC Vaccine Combo Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the NANT HNSCC Vaccine Combo Immunotherapy Clinical Trial page.

Latest updates to the NANT HNSCC Vaccine Combo Immunotherapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays the QUILT-3.047 study record for combination immunotherapy in head and neck squamous cell carcinoma, with enrollment reported as zero and the trial marked withdrawn and not initiated.SummaryDifference80%

- Check19 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check33 days agoChange DetectedThe footer site revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe revision identifier in the footer advances from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check61 days agoChange DetectedThe study page for NCT03169764 now displays a 403 Forbidden error, preventing access to the study record and related details on ClinicalTrials.gov. This blocks core content and disrupts users' ability to review the trial information.SummaryDifference24%

Stay in the know with updates to NANT HNSCC Vaccine Combo Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NANT HNSCC Vaccine Combo Immunotherapy Clinical Trial page.